Physician profile
Melanie Powell
NPI 1811973464
$1,467.30
in general payments reported to CMS, 2019-2025
19 companies · $584 in 2025
The $584 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.27 · 2020: $126 · 2021: $111 · 2022: $71.27 · 2023: $178 · 2024: $371 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $618.35 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $208.48 | 2020-2025 | Zepbound, Mounjaro, Kisunla |
| Abbvie INC. | $161.15 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $85.47 | 2020-2024 | Airsupra, Fasenra |
| Bayer Healthcare Pharmaceuticals INC. | $74.32 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $63.29 | 2024-2025 | Vaxelis, Gardasil 9, Gardasil |
| Sanofi Pasteur INC. | $43.34 | 2019-2021 | |
| Pfizer INC. | $32.36 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $30.60 | 2021-2023 | |
| Exact Sciences Corporation | $20.70 | 2025 | Cologuard Collection Kit |
| Modernatx, INC. | $18.00 | 2025 | Mresvia |
| Otsuka America Pharmaceutical, INC. | $16.36 | 2025 | Rexulti |
| Phadia US INC. | $16.32 | 2025 | Immunocap |
| Astellas Pharma US INC | $13.99 | 2024 | Xospata |
| Biohaven Pharmaceutical Holding Company LTD. | $13.55 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.32 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.00 | 2021 | |
| Horizon Therapeutics Plc | $12.70 | 2022 | |
| Amgen INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.